Gütersloh, Germany – 21 May 2025 – cormeo, the newly established Pharma Tech holding company under Bertelsmann Investments, is excited to announce the 100% acquisition of Docuvera, a pioneer and leading provider of AI-powered structured content authoring for the life sciences industry.

Initially, Bertelsmann Investments held a minority stake in Docuvera, with an investment in the mid-single-digit million Euro range. Based on a successful and forward-looking collaboration that has rooted in a shared vision for the future of content management, cormeo has now increased its stake to 100%. This strategic move underscores cormeo’s continued commitment to integrating innovative, cutting-edge technology into its portfolio of brands.

Docuvera has established itself as a critical player in life sciences content management, providing organizations with forward-thinking technology solutions that deliver remarkable content authoring efficiencies while reducing both compliance risks and time to market. Bringing Docuvera fully under the cormeo umbrella furthers the company’s mission to accelerate the development of next-generation solutions that harness the power of artificial intelligence (AI) and structured content.

Acquiring Docuvera is a pivotal step in our journey toward realizing a seamless, end-to-end information lifecycle,” said Tobias Beer, COO of cormeo and Member of the Advisory Board at Docuvera. “With Docuvera’s strengths in structured content authoring and AI, we can empower our clients to streamline content operations, enhance efficiency, and reduce compliance risk through greater consistency and traceability of regulated content.”

Docuvera joins the ranks of cormeo's other innovative brands, EXTEDO and Rote Liste, further solidifying its position as a comprehensive solution provider in the life sciences information management landscape. This acquisition strengthens cormeo’s capabilities, offering clients an integrated suite of complementary tools designed to optimize content creation and management throughout the lifecycle.

As part of cormeo's commitment to innovation and customer success, the integration of Docuvera expands and accelerates the focus on delivering enhanced features and functionalities that cater to the evolving needs of organizations in the life sciences sector. The combination of cormeo's vision and Docuvera's technology will unlock new opportunities for clients to harness the full potential of their content creation and processing.

"We are thrilled to fully join the cormeo portfolio," said Stephen Owens, newly appointed CEO of Docuvera. "Together, we will continue to push the boundaries of what is possible in life sciences content management, providing solutions for customers to thrive in an increasingly digital world."

About Docuvera

Docuvera Software Corporation (Docuvera) is a globally recognized leader in structured content authoring solutions for the pharmaceutical and life sciences industries. Headquartered in New Zealand, Docuvera solutions have been implemented world-wide for more than a decade to strengthen regulatory compliance and governance as well as significantly improve content standardization/reuse efficiency and approval submissions/time to market.

The company’s embedding of its proprietary artificial intelligence (AI) into the solution has further fortified the Docuvera value proposition as a sought-after solution for pharmaceutical and life sciences documentation use cases, as well as a platform for customers to further digital transformation initiatives. For more information, visit https://docuvera.com.